Profile cover photo
Profile photo
Genes Diseases
7 followers -
an international journal for molecular and translational medicine
an international journal for molecular and translational medicine

7 followers
About
Posts

Post has attachment
Photo
Add a comment...

Post has attachment
Photo
Add a comment...

Post has attachment
Genes & Diseases
an international journal for molecular and translational medicine
 
 
ISSN Print Edition: 2352-4820
ISSN Online Edition: 2352-3042
Journal Homepage: www.genesndiseases.org
Publication: Genes & Diseases is published 4 times a year.
Copyright: ©2014 Chongqing Medical University.
Production and Hosting by ELSEVIER B. V.
Add a comment...

Add a comment...

Editor-in-Chief
T.-C. He, MD, PhD (H index=54) is a well-established investigator with more than 20-year-experience in basic biomedical and translational research, including cell signaling, cancer biology, stem cell biology, gene and cell-based therapies, and regenerative medicine. He is currently a tenured faculty member and the director of Molecular Oncology Laboratory at The University of Chicago Medical Center. Dr. He received his medical school training from Chongqing Medical University in China and his PhD degree in molecular and cell biology from the Pennsylvania State University, followed by a postdoctoral training at Howard Hughes Medical Institute and Johns Hopkins Medical Institution. He was the principal developer of the highly-cited, widely-used AdEasy technology, which has streamlined the effective generation of recombinant adenoviruses. He has co-authored more than 190 peer-reviewed original articles, invited reviews, and book chapters, which have been cumulatively cited more than 18,000 times according to Google Scholar. In addition to his research activities, Dr. He has actively participated in the peer reviewing process for more than 30 journals, including many top tier journals. He is currently serving on the editorial boards for over 10 journals, including Journal of Biological Chemistry, Current Cancer Drug Targets, Laboratory Investigation, and American Journal of Stem Cells.
Add a comment...

Editorial Board
The Editorial Board of Genes & Diseases is comprised of 82 experts from 17 countries in 15 disciplines. There
are 67 oversea editorial board members, accounting for 81.7% of the total number. The Advisory Board is chaired
by the president of Chongqing Medical University, professor Han Lei and is supported by 9 academicians from
the Chinese Academy of Engineering or the Chinese Academy of Sciences.
Add a comment...

Editorial Process
All manuscripts received are duly acknowledged. Upon submission, the Editorial Office will check the manuscript’s conformity to technical quality and author guidelines, typically within one week. Manuscripts with insufficient conformity are returned to authors for revision. Manuscripts with insufficient originality, serious scientific or experimental flaws, or lack of interest to the readership of Genes & Diseases will be rejected by the Editor-in-Chief and/or Deputy Editor-in-Chief without further peer review. Manuscripts deemed suitable for publication are sent to the Executive Associate Editors. The Executive Associate Editors will make initial assessment and will serve as the managing editor, who in turn will appoint 2-3 editorial board members and/or external referees to complete peer reviews within 4 weeks. Based on the recommendations and comments made by peer reviewers, the Executive Associate Editor will make a formal recommendation to the Editor-in-Chief and/or Deputy Editor-in-Chief who will make the final decision within 1 week, in consultation with other editorial board members, if deemed necessary. The comments and recommendations (acceptance/ rejection/ minor revision/ major revision in manuscript) received from reviewers are conveyed to the corresponding author. If necessary, the author is required to provide a point by point response to reviewers’ comments and submit a revised manuscript. This process will be repeated till reviewers and editors are satisfied with the revised manuscript.
 
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within 48 hours. The whole process of submission of the manuscript, final decision, sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as ‘Ahead of Print’ immediately upon acceptance.
Add a comment...

Aims and Scopes
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis will be placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Add a comment...

About the Journal
Genes & Diseases is an international journal for molecular and translational medicine. The journal primarily focuses on publishing investigations on the molecular bases and experimental therapeutics of human diseases. Publication formats include full length article, review article, short communication, correspondence, perspectives, commentary, views on news, and research watch.
Add a comment...
Wait while more posts are being loaded